Coverart for item
The Resource Atlas of rheumatoid arthritis, Paul Emery, editor, (electronic book)

Atlas of rheumatoid arthritis, Paul Emery, editor, (electronic book)

Label
Atlas of rheumatoid arthritis
Title
Atlas of rheumatoid arthritis
Statement of responsibility
Paul Emery, editor
Contributor
Subject
Genre
Language
eng
Summary
Atlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA. Rheumatoid arthritis (RA) is the most common and most serious of the inflammatory arthritic disorders, and it dominates clinical rheumatological practice. Effective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly
Member of
Cataloging source
AU-PeEL
Dewey number
616.991
LC call number
RC933 .E384 2015
Nature of contents
dictionaries
http://library.link/vocab/relatedWorkOrContributorName
Emery, Paul
http://library.link/vocab/subjectName
  • Rheumatoid arthritis
  • Rheumatoid arthritis
  • Rheumatoid arthritis
  • Joints
  • Arthritis, Rheumatoid
  • Arthritis, Rheumatoid
Label
Atlas of rheumatoid arthritis, Paul Emery, editor, (electronic book)
Instantiates
Publication
Contents
  • Contents; PART ONE Rheumatoid arthritis overview; 1 Classification ofrheumatoid arthritis; References; 2 Pre- rheumatoid arthritis; What is pre-rheumatoid arthritis?; Risk factors for rheumatoid arthritis; Systemic autoimmunity associated with rheumatoid arthritis; Symptoms without clinical arthritis; Unclassified arthritis; References; 3 Early rheumatoid arthritis; Introduction; Pathology in early rheumatoid arthritis; Diagnosis of early rheumatoid arthritis; Classification of rheumatoid arthritis; Management of early rheumatoid arthritis
  • Recommendations for the management of early rheumatoid arthritisReferences; 4 Established rheumatoidarthritis; Introduction; Stages of established rheumatoid arthritis; Common clinical presentations; References; 5 Remission and rheumatoidarthritis ; Introduction; Defining remission; Imaging remission; Immune-mediated remission; Drug-free remission; Optimal dose reduction regimes for patients in remission; References; PART TWO Imaging of rheumatoid arthritis; 6 Magnetic resonance imaging in rheumatoid arthritis; Introduction; Technical aspects; Visualizing rheumatoid arthritis
  • Diagnosing rheumatoid arthritisMonitoring disease activity and structural damage; References; 7 Ultrasound imaging in rheumatoidarthritis; Introduction; Ultrasound and rheumatoid arthritis; Cartilage damage; Management of rheumatoid arthritis with ultrasound: diagnosis,therapeutic follow-up, remission, and flare; Conclusion; References; 8 Dual energy X-ray absorptiometry in rheumatoid arthritis; Introduction; Bone remodeling in rheumatoid arthritis; Bone damage imaging in rheumatoid arthritis; Treatment of bone loss in rheumatoid arthritis; References
  • PART THREE Treatment of rheumatoid arthritis9Methotrexate; Introduction; Historical perspective; Mechanism of action and pharmacokinetics; Dosing; Benefits; Monitoring; Side effects; References; 10 Immunotherapy; Introduction; Nonbiologic disease-modifying antirheumatic drugs; Biologic disease-modifying antirheumatic drugs; Cost-effectiveness of immunotherapy in early rheumatoid arthritis; Recommendations for the use of disease-modifying antirheumaticdrug therapies; Safety of immunotherapy; Prospective new targets for immunotherapy; References; 11 Rituximab
  • B-cell development and differentiationEfficacy of rituximab in rheumatoid arthritis; 12 Novel therapies in rheumatoidarthritis: small molecules; Introduction; Inhibiting intracellular signaling pathways; Conclusion; References
Control code
PURCH EBC2094030
Dimensions
unknown
Extent
1 online resource (269 p.)
Form of item
electronic
Isbn
9781907673900
Isbn Type
(pbk)
Specific material designation
remote
Label
Atlas of rheumatoid arthritis, Paul Emery, editor, (electronic book)
Publication
Contents
  • Contents; PART ONE Rheumatoid arthritis overview; 1 Classification ofrheumatoid arthritis; References; 2 Pre- rheumatoid arthritis; What is pre-rheumatoid arthritis?; Risk factors for rheumatoid arthritis; Systemic autoimmunity associated with rheumatoid arthritis; Symptoms without clinical arthritis; Unclassified arthritis; References; 3 Early rheumatoid arthritis; Introduction; Pathology in early rheumatoid arthritis; Diagnosis of early rheumatoid arthritis; Classification of rheumatoid arthritis; Management of early rheumatoid arthritis
  • Recommendations for the management of early rheumatoid arthritisReferences; 4 Established rheumatoidarthritis; Introduction; Stages of established rheumatoid arthritis; Common clinical presentations; References; 5 Remission and rheumatoidarthritis ; Introduction; Defining remission; Imaging remission; Immune-mediated remission; Drug-free remission; Optimal dose reduction regimes for patients in remission; References; PART TWO Imaging of rheumatoid arthritis; 6 Magnetic resonance imaging in rheumatoid arthritis; Introduction; Technical aspects; Visualizing rheumatoid arthritis
  • Diagnosing rheumatoid arthritisMonitoring disease activity and structural damage; References; 7 Ultrasound imaging in rheumatoidarthritis; Introduction; Ultrasound and rheumatoid arthritis; Cartilage damage; Management of rheumatoid arthritis with ultrasound: diagnosis,therapeutic follow-up, remission, and flare; Conclusion; References; 8 Dual energy X-ray absorptiometry in rheumatoid arthritis; Introduction; Bone remodeling in rheumatoid arthritis; Bone damage imaging in rheumatoid arthritis; Treatment of bone loss in rheumatoid arthritis; References
  • PART THREE Treatment of rheumatoid arthritis9Methotrexate; Introduction; Historical perspective; Mechanism of action and pharmacokinetics; Dosing; Benefits; Monitoring; Side effects; References; 10 Immunotherapy; Introduction; Nonbiologic disease-modifying antirheumatic drugs; Biologic disease-modifying antirheumatic drugs; Cost-effectiveness of immunotherapy in early rheumatoid arthritis; Recommendations for the use of disease-modifying antirheumaticdrug therapies; Safety of immunotherapy; Prospective new targets for immunotherapy; References; 11 Rituximab
  • B-cell development and differentiationEfficacy of rituximab in rheumatoid arthritis; 12 Novel therapies in rheumatoidarthritis: small molecules; Introduction; Inhibiting intracellular signaling pathways; Conclusion; References
Control code
PURCH EBC2094030
Dimensions
unknown
Extent
1 online resource (269 p.)
Form of item
electronic
Isbn
9781907673900
Isbn Type
(pbk)
Specific material designation
remote

Library Locations

Processing Feedback ...